Clinical Trials Browser

Phase 1 × OTHER × Turcot syndrome × Clear all

NCT07385846 2026-02-04

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

Phase 1 Not yet recruiting

Turcot syndrome, Glioblastoma